What is the step‑by‑step management of a patient with severe hypocalcemia?

Management of Severe Hypocalcemia

For severe hypocalcemia (ionized calcium <1 mmol/L or symptomatic), immediate intravenous calcium gluconate infusion is essential to prevent life-threatening complications including ventricular arrhythmias, seizures, and tetany. 1, 2

Immediate Assessment and Stabilization

Initial Evaluation

• Measure ionized calcium, magnesium, phosphate, PTH, creatinine, and obtain ECG to assess for QT prolongation and cardiac arrhythmias 3
• Check 25-hydroxyvitamin D levels to identify vitamin D deficiency 3
• Assess for precipitating factors: recent surgery (especially thyroid/parathyroid), acute illness, medications (cinacalcet, bisphosphonates), renal failure, or hypomagnesemia 3

Acute Treatment Protocol

For moderate to severe hypocalcemia (ionized calcium <1 mmol/L):

• Administer 4 grams of calcium gluconate IV infused at 1 g/hour - this regimen successfully achieves ionized calcium >1 mmol/L in 95% of critically ill patients 4
• Monitor for hypercalcemia during infusion (occurs in ~10% of cases) 4
• Recheck ionized calcium within 24 hours to guide further management 4

For symptomatic hypocalcemia with tetany, seizures, or arrhythmias:

• Administer IV calcium gluconate more rapidly under continuous cardiac monitoring 1, 2
• Treat seizures with calcium correction first; anticonvulsants may be needed if seizures persist after calcium normalization 3

Correct Underlying Electrolyte Abnormalities

Magnesium Replacement

Hypomagnesemia must be corrected before hypocalcemia can be effectively treated 3

• Measure serum magnesium in all hypocalcemic patients 3
• Provide magnesium supplementation for levels below normal range 3
• In primary hypomagnesemia with secondary hypocalcemia, oral magnesium sulfate is the definitive treatment 5

Phosphate Assessment

• Evaluate phosphate levels as hyperphosphatemia or hypophosphatemia may indicate specific etiologies 3
• In CKD patients, manage phosphate with dietary modification and phosphate binders if elevated 3

Identify and Treat the Underlying Cause

Hypoparathyroidism (Low/Inappropriately Normal PTH)

Most common cause is postsurgical hypoparathyroidism 2, 6

• Start oral calcium supplementation (typically 1-3 grams elemental calcium daily in divided doses) 3
• Add active vitamin D metabolites for severe cases: calcitriol 0.5-0.75 μg daily or alfacalcidol 0.75-1.5 μg daily in adults 3
• Consultation with endocrinology is recommended for active vitamin D dosing 3
• Monitor urinary calcium to prevent hypercalciuria, nephrocalcinosis, and renal failure - keep within normal range 3

Vitamin D Deficiency (Elevated PTH)

• Supplement with native vitamin D (cholecalciferol or ergocalciferol) to achieve 25-OH vitamin D >20 ng/mL (50 nmol/L) 3
• Ensure adequate dietary calcium intake meeting age-related recommended allowances 3
• Low urinary calcium suggests calcium/vitamin D deprivation requiring supplementation 3

CKD-Related Hypocalcemia

• Manage secondary hyperparathyroidism with phosphate control, vitamin D supplementation, and dialysis adjustment 3
• Consider calcimimetics (cinacalcet) for refractory cases, but use with extreme caution as it can worsen hypocalcemia and prolong QT interval 3

Post-Parathyroidectomy "Hungry Bone Syndrome"

• Anticipate severe hypocalcemia from rapid bone remineralization 3
• Preoperative and postoperative active vitamin D may reduce severe hypocalcemia incidence 3
• Aggressive calcium and vitamin D supplementation, potentially with high-calcium dialysate if on dialysis 3

Ongoing Monitoring and Maintenance

Short-Term Monitoring

• Recheck ionized calcium, magnesium, and phosphate within 24 hours of initial treatment 4
• Monitor ECG for QT interval normalization 3
• Assess for resolution of neuromuscular symptoms (tetany, paresthesias, seizures) 2, 6

Long-Term Management

• For chronic hypoparathyroidism, maintain serum calcium in the low-normal range to minimize hypercalciuria and prevent nephrocalcinosis, renal calculi, and renal failure 3, 6
• Monitor calcium, PTH, magnesium, creatinine, and urinary calcium regularly 3
• Increase monitoring during high-risk periods: perioperatively, during pregnancy/childbirth, acute illness, or immobilization 3

Treatment Adjustments

• If hypercalciuria or hypercalcemia develops, reduce or stop active vitamin D and calcium supplements 3
• Consider measures to decrease urinary calcium: adequate hydration, potassium citrate, limited sodium intake 3
• Recombinant human PTH(1-84) is FDA/EMA approved for hypoparathyroidism refractory to conventional therapy, though cost limits widespread use 2

Critical Pitfalls to Avoid

• Never overlook hypomagnesemia - hypocalcemia cannot be corrected without adequate magnesium 3, 5
• Avoid overcorrection - iatrogenic hypercalcemia can cause renal calculi and renal failure, particularly when treatment compliance improves unexpectedly 3
• Do not use cinacalcet in hypocalcemic patients - it worsens hypocalcemia and increases QT interval 3
• Screen for hypocalcemia before administering bisphosphonates to prevent severe acute hypocalcemia 7
• Avoid alcohol and cola beverages as they worsen hypocalcemia 3